They target the same outcome (tissue repair) through different mechanisms : BPC-157: local growth factor expression, fibroblast stimulation, angiogenesis at the injury site TB-500: systemic cell migration, actin regulation, reduction of chronic inflammation throughout the body Standard Wolverine stack: BPC-157: 250500 mcg SC twice daily , injected near the injury site where possible TB-500: 22.5 mg SC twice weekly loading (weeks 14), then 2 mg weekly maintenance (weeks 512) CRITICAL: do not mix in the same vial - they can be injected in the same session but must remain in separate solutions
Immunostimulation in the era of the metagenome
Peptide therapy is best understood as an addition to a comprehensive PMOS management strategy, not a replacement for it
[47] Low vitamin concentrations in human milk occur in families with low socioeconomic status or low consumption of animal products
Recent FDA action against misleading compounded-GLP-1 advertising is a reminder that business incentives in this space can distort how therapies are presented to patients
This means the B12 is injected into the fatty tissue just beneath the skin
